FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2559715817> ?p ?o ?g. }

• W2559715817 abstract "Abstract Abstract 1000 The treatment of acute myeloid leukemia (AML) poses a vexing challenge despite an improved understanding of its molecular pathogenesis. A two-hit theory has been proposed for the pathogenesis of AML where the first hit imparts a proliferation defect and the second a block in differentiation. Drug discovery efforts for AML, however, have largely focused on the proliferation defect. Using the intersection of chemical biology and high-throughput genetic screening we sought to identify new AML differentiation targets by measuring the induction of a complex gene expression signature of myeloid maturation. We performed two independent small molecule library screens and a high-throughput shRNA screen for perturbations that induce differentiation in AML cells. We measured this differentiation signature using the previously described gene expression-based high-throughput screening (GE-HTS) approach in which gene expression signatures serve as surrogates for different biological states. Glycogen Synthase Kinase-3 (GSK-3) emerged as a target at the intersection of these three screens. GSK-3 is a multifunctional serine threonine kinase involved in diverse cellular processes including differentiation, signal transduction, cell cycle regulation and proliferation, with an emerging role in human leukemia. We demonstrate that the GSK-3 inhibitors scoring in the primary screens indeed induce the differentiation signature with a dose-response in AML cell lines. In order to further validate GSK-3 as a target, we extended testing to lithium chloride and SB216763, two commonly used GSK-3 inhibitors not in the original screens. Both of these molecules induced AML differentiation as measured by gene expression and morphological changes in multiple AML cell lines and in primary patient blasts in vitro. GSK-3 is expressed as two highly homologous but non-redundant isoforms, GSK-3α and GSK-3β, with small molecule inhibitors non-selectively reported to target both. In order to further validate the findings of the small molecule library screens, we performed a high-throughput shRNA screen targeting the human kinome for shRNAs that induce differentiation. Multiple hairpins against GSK-3α scored. In secondary testing of four AML cell lines, we found that genetic loss of GSK-3α induced differentiation as measured by induction of the complex gene expression signature, alterations in genome-wide expression, and morphological changes associated with maturation. Moreover, colony formation in methylcellulose was impeded. These effects could be rescued with a GSK-3α cDNA immune to the effects of the shRNA, further supporting the on-target activity of the hairpin. In contrast, GSK-3β-directed hairpins induced minimal differentiation. We next extended testing to an in vivo U937 orthotopic model of AML. While pan-GSK-3 inhibition with lithium chloride treatment did not demonstrate efficacy in this model, inhibition of GSK-3α with shRNA attenuated development of disease compared to an shRNA control. We hypothesize that the rise in β-catenin with pan-inhibition of GSK-3 may attenuate the response to lithium in vivo. In contrast, isolated knockdown of GSK-3α does not induce β-catenin. While much of the prior cancer literature has focused on the role of GSK-3β in human malignancy, these studies suggest a role for GSK-3α in AML differentiation and support a role for GSK-3α-directed targeted therapy. Disclosures: No relevant conflicts of interest to declare." @default.
• W2559715817 created "2016-12-08" @default.
• W2559715817 creator A5007788682 @default.
• W2559715817 creator A5009207051 @default.
• W2559715817 creator A5011985711 @default.
• W2559715817 creator A5017574761 @default.
• W2559715817 creator A5022958263 @default.
• W2559715817 creator A5029365172 @default.
• W2559715817 creator A5036736992 @default.
• W2559715817 creator A5042911522 @default.
• W2559715817 creator A5046655874 @default.
• W2559715817 creator A5051795460 @default.
• W2559715817 creator A5053674036 @default.
• W2559715817 creator A5057509500 @default.
• W2559715817 creator A5063875415 @default.
• W2559715817 creator A5071023119 @default.
• W2559715817 creator A5082560419 @default.
• W2559715817 creator A5082924494 @default.
• W2559715817 date "2010-11-19" @default.
• W2559715817 modified "2023-10-02" @default.
• W2559715817 title "Intersecting Chemical Genomic and Genetic Screens Identifies Glycogen Synthase Kinase-3α (GSK-3α) as a Modulator of Differentiation In Acute Myeloid Leukemia" @default.
• W2559715817 doi "https://doi.org/10.1182/blood.v116.21.1000.1000" @default.
• W2559715817 hasPublicationYear "2010" @default.
• W2559715817 type Work @default.
• W2559715817 sameAs 2559715817 @default.
• W2559715817 citedByCount "0" @default.
• W2559715817 crossrefType "journal-article" @default.
• W2559715817 hasAuthorship W2559715817A5007788682 @default.
• W2559715817 hasAuthorship W2559715817A5009207051 @default.
• W2559715817 hasAuthorship W2559715817A5011985711 @default.
• W2559715817 hasAuthorship W2559715817A5017574761 @default.
• W2559715817 hasAuthorship W2559715817A5022958263 @default.
• W2559715817 hasAuthorship W2559715817A5029365172 @default.
• W2559715817 hasAuthorship W2559715817A5036736992 @default.
• W2559715817 hasAuthorship W2559715817A5042911522 @default.
• W2559715817 hasAuthorship W2559715817A5046655874 @default.
• W2559715817 hasAuthorship W2559715817A5051795460 @default.
• W2559715817 hasAuthorship W2559715817A5053674036 @default.
• W2559715817 hasAuthorship W2559715817A5057509500 @default.
• W2559715817 hasAuthorship W2559715817A5063875415 @default.
• W2559715817 hasAuthorship W2559715817A5071023119 @default.
• W2559715817 hasAuthorship W2559715817A5082560419 @default.
• W2559715817 hasAuthorship W2559715817A5082924494 @default.
• W2559715817 hasConcept C104317684 @default.
• W2559715817 hasConcept C104629339 @default.
• W2559715817 hasConcept C148738053 @default.
• W2559715817 hasConcept C173396325 @default.
• W2559715817 hasConcept C182996813 @default.
• W2559715817 hasConcept C190232843 @default.
• W2559715817 hasConcept C2778461978 @default.
• W2559715817 hasConcept C2778729363 @default.
• W2559715817 hasConcept C502942594 @default.
• W2559715817 hasConcept C54355233 @default.
• W2559715817 hasConcept C62112901 @default.
• W2559715817 hasConcept C62478195 @default.
• W2559715817 hasConcept C75217442 @default.
• W2559715817 hasConcept C81885089 @default.
• W2559715817 hasConcept C86803240 @default.
• W2559715817 hasConcept C95444343 @default.
• W2559715817 hasConceptScore W2559715817C104317684 @default.
• W2559715817 hasConceptScore W2559715817C104629339 @default.
• W2559715817 hasConceptScore W2559715817C148738053 @default.
• W2559715817 hasConceptScore W2559715817C173396325 @default.
• W2559715817 hasConceptScore W2559715817C182996813 @default.
• W2559715817 hasConceptScore W2559715817C190232843 @default.
• W2559715817 hasConceptScore W2559715817C2778461978 @default.
• W2559715817 hasConceptScore W2559715817C2778729363 @default.
• W2559715817 hasConceptScore W2559715817C502942594 @default.
• W2559715817 hasConceptScore W2559715817C54355233 @default.
• W2559715817 hasConceptScore W2559715817C62112901 @default.
• W2559715817 hasConceptScore W2559715817C62478195 @default.
• W2559715817 hasConceptScore W2559715817C75217442 @default.
• W2559715817 hasConceptScore W2559715817C81885089 @default.
• W2559715817 hasConceptScore W2559715817C86803240 @default.
• W2559715817 hasConceptScore W2559715817C95444343 @default.
• W2559715817 hasLocation W25597158171 @default.
• W2559715817 hasOpenAccess W2559715817 @default.
• W2559715817 hasPrimaryLocation W25597158171 @default.
• W2559715817 hasRelatedWork W125900404 @default.
• W2559715817 hasRelatedWork W2016434015 @default.
• W2559715817 hasRelatedWork W2036611565 @default.
• W2559715817 hasRelatedWork W2114918622 @default.
• W2559715817 hasRelatedWork W2147432075 @default.
• W2559715817 hasRelatedWork W2259246578 @default.
• W2559715817 hasRelatedWork W2270859085 @default.
• W2559715817 hasRelatedWork W2492982804 @default.
• W2559715817 hasRelatedWork W2522386126 @default.
• W2559715817 hasRelatedWork W2522819168 @default.
• W2559715817 hasRelatedWork W2565332683 @default.
• W2559715817 hasRelatedWork W2589251603 @default.
• W2559715817 hasRelatedWork W2593557791 @default.
• W2559715817 hasRelatedWork W2791039527 @default.
• W2559715817 hasRelatedWork W2799707898 @default.
• W2559715817 hasRelatedWork W2917875073 @default.
• W2559715817 hasRelatedWork W2980264254 @default.
• W2559715817 hasRelatedWork W3035059775 @default.
• W2559715817 hasRelatedWork W3181329052 @default.
• W2559715817 hasRelatedWork W2839779790 @default.
• W2559715817 isParatext "false" @default.
• W2559715817 isRetracted "false" @default.

• next